Literature DB >> 33761890

A 2 miRNAs-based signature for the diagnosis of atherosclerosis.

Xiujiang Han1, Huimin Wang2, Yongjian Li3, Lina Liu1, Sheng Gao4.   

Abstract

BACKGROUND: Atherosclerosis (AS) is a leading cause of vascular disease worldwide. MicroRNAs (miRNAs) play an essential role in the development of AS. However, the miRNAs-based biomarkers for the diagnosis of AS are still limited. Here, we aimed to identify the miRNAs significantly related to AS and construct the predicting model based on these miRNAs for distinguishing the AS patients from healthy cases.
METHODS: The miRNA and mRNA expression microarray data of blood samples from patients with AS and healthy cases were obtained from the GSE59421 and GSE20129 of Gene Expression Omnibus (GEO) database, respectively. Weighted Gene Co-expression Network Analysis (WGCNA) was performed to evaluate the correlation of the miRNAs and mRNAs with AS and identify the miRNAs and mRNAs significantly associated with AS. The potentially critical miRNAs were further optimized by functional enrichment analysis. The logistic regression models were constructed based on these optimized miRNAs and validated by threefold cross-validation method.
RESULTS: WGCNA revealed 42 miRNAs and 532 genes significantly correlated with AS. Functional enrichment analysis identified 12 crucial miRNAs in patients with AS. Moreover, 6 miRNAs among the identified 12 miRNAs, were selected using a stepwise regression model, in which four miRNAs, including hsa-miR-654-5p, hsa-miR-409-3p, hsa-miR-485-5p and hsa-miR-654-3p, were further identified through multivariate regression analysis. The threefold cross-validation method showed that the AUC of logistic regression model based on the four miRNAs was 0.7308, 0.8258, and 0.7483, respectively, with an average AUC of 0.7683.
CONCLUSION: We identified a total of four miRNAs, including hsa-miR-654-5p and hsa-miR-409-3p, are identified as the potentially critical biomarkers for AS. The logistic regression model based on the identified 2 miRNAs could reliably distinguish the patients with AS from normal cases.

Entities:  

Keywords:  Atherosclerosis; Diagnosis; Logistic regression model; Signature; WGCNA; miRNAs

Year:  2021        PMID: 33761890     DOI: 10.1186/s12872-021-01960-4

Source DB:  PubMed          Journal:  BMC Cardiovasc Disord        ISSN: 1471-2261            Impact factor:   2.298


  34 in total

Review 1.  Atherosclerosis.

Authors:  Peter Libby; Julie E Buring; Lina Badimon; Göran K Hansson; John Deanfield; Márcio Sommer Bittencourt; Lale Tokgözoğlu; Eldrin F Lewis
Journal:  Nat Rev Dis Primers       Date:  2019-08-16       Impact factor: 52.329

Review 2.  Mechanisms of plaque formation and rupture.

Authors:  Jacob Fog Bentzon; Fumiyuki Otsuka; Renu Virmani; Erling Falk
Journal:  Circ Res       Date:  2014-06-06       Impact factor: 17.367

Review 3.  Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease.

Authors:  William Herrington; Ben Lacey; Paul Sherliker; Jane Armitage; Sarah Lewington
Journal:  Circ Res       Date:  2016-02-19       Impact factor: 17.367

4.  Both gut microbiota and cytokines act to atherosclerosis in ApoE-/- mice.

Authors:  Qiuxia Liu; Yuchuan Li; Xue Song; Jing Wang; Zebao He; Jiansheng Zhu; Huazhong Chen; Jing Yuan; Xue Zhang; Haiyin Jiang; Sheng Zhang; Bing Ruan
Journal:  Microb Pathog       Date:  2019-11-01       Impact factor: 3.738

Review 5.  Progress and challenges in translating the biology of atherosclerosis.

Authors:  Peter Libby; Paul M Ridker; Göran K Hansson
Journal:  Nature       Date:  2011-05-19       Impact factor: 49.962

6.  Atherosclerosis knowledge - diagnosis and management in primary care.

Authors:  Marie Charasson; Guillaume Mahé; Charles Le Brun; Vincent Jaquinandi; Emilie Rossignol; Alexis Le Faucheur; Loukman Omarjee
Journal:  Vasa       Date:  2018-07-26       Impact factor: 1.961

Review 7.  Mechanotransduction in vascular physiology and atherogenesis.

Authors:  Cornelia Hahn; Martin A Schwartz
Journal:  Nat Rev Mol Cell Biol       Date:  2009-01       Impact factor: 94.444

8.  Analysis of gene expression profile identifies potential biomarkers for atherosclerosis.

Authors:  Luran Liu; Yan Liu; Chang Liu; Zhuobo Zhang; Yaojun Du; Hao Zhao
Journal:  Mol Med Rep       Date:  2016-08-19       Impact factor: 2.952

Review 9.  Application of Metabolomics to Epidemiological Studies of Atherosclerosis and Cardiovascular Disease.

Authors:  Miho Iida; Sei Harada; Toru Takebayashi
Journal:  J Atheroscler Thromb       Date:  2019-08-02       Impact factor: 4.928

10.  Intercellular adhesion molecule-1 expression and serum levels as markers of pre-clinical atherosclerosis in polycystic ovary syndrome.

Authors:  Nearmeen M Rashad; Amal S El-Shal; Hala G Abomandour; Amr Mostafa Kamel Aboelfath; Mohamed El Sayed Rafeek; Mohammad Samir Badr; Ayman E Ali; Mohammed S Yousef; Maha Abdelhamid Fathy; Mustafa Taha Abdelfattah Sharaf El Din
Journal:  J Ovarian Res       Date:  2019-10-19       Impact factor: 4.234

View more
  4 in total

1.  MicroRNAs in peripheral artery disease: potential biomarkers and pathophysiological mechanisms.

Authors:  Andrew Ring; Ahmed Ismaeel; Marissa Wechsler; Emma Fletcher; Evlampia Papoutsi; Dimitrios Miserlis; Panagiotis Koutakis
Journal:  Ther Adv Cardiovasc Dis       Date:  2022 Jan-Dec

2.  Construction of a circRNA-miRNA-mRNA Regulatory Network for Coronary Artery Disease by Bioinformatics Analysis.

Authors:  Zebo Zhang; Haiyan Qian; Li Wang; Zhenbo Tao; Keai Cheng; Kaiyue Wang; Yanqing Xie; Lina Zhang
Journal:  Cardiol Res Pract       Date:  2022-02-16       Impact factor: 1.866

3.  Characteristic MicroRNAs Linked to Dysregulated Metabolic Pathways in Qatari Adult Subjects With Obesity and Metabolic Syndrome.

Authors:  Fayaz Ahmad Mir; Raghvendra Mall; Ahmad Iskandarani; Ehsan Ullah; Tareq A Samra; Farhan Cyprian; Aijaz Parray; Meis Alkasem; Ibrahem Abdalhakam; Faisal Farooq; Abdul-Badi Abou-Samra
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

4.  Bioinformatics analysis to identify potential biomarkers and therapeutic targets for ST-segment-elevation myocardial infarction-related ischemic stroke.

Authors:  Shuo Feng; Rui Li; Qingqing Zhou; Fengling Qu; Wei Hu; Xinfeng Liu
Journal:  Front Neurol       Date:  2022-08-11       Impact factor: 4.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.